Microbiology and Infectious Disease Surveillance: The Post-Pandemic Laboratory
The COVID-19 pandemic permanently altered the landscape of Medical Microbiology in Germany. In 2026, laboratories maintain significantly higher PCR capacities and have integrated Wastewater Monitoring and Genomic Surveillance into their routine activities to detect emerging pathogens early.
The Infection Protection Act (IfSG) mandates that laboratories report detections of specific pathogens (e.g., MRSA, Influenza, Measles) directly to local health authorities (Gesundheitsämter) via the digital "DEMIS" reporting system. This real-time surveillance allows for rapid public health responses. Furthermore, the focus has shifted toward "syndromic testing," where a single sample can be screened for a panel of 20+ respiratory or gastrointestinal pathogens simultaneously, providing clinicians with a complete diagnostic picture within hours.